Paper · 42880979
Neuro-associated SEMA3C+ tumour cells promote gastric cancer peritoneal metastasis via EBF2-FGF7-FGFR2-mediated tumour-endothelial crosstalk.
Zhou Y and 12 others. Clin Transl Med, 2026.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Neuro-associated SEMA3C+ tumour cells promote gastric cancer peritoneal metastasis via EBF2-FGF7-FGFR2-mediated tumour-endothelial crosstalk. Papers, record 42880979. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42880979
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Neuro-associated SEMA3C+ tumour cells promote gastric cancer peritoneal metastasis via EBF2-FGF7-FGFR2-mediated tumour-endothelial crosstalk.
- Journal
- Clin Transl Med
- Year
- 2026
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't
- Revised in PubMed
- 2026-11-02
Source PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Stomach Neoplasms | Major topic |
| Semaphorins | Major topic |
| Receptor, Fibroblast Growth Factor, Type 2 | Major topic |
| Peritoneal Neoplasms | Major topic |
| Humans | |
| Animals | |
| Mice | |
| Tumor Microenvironment |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 82372887 | National Natural Science Foundation of China | PubMed | PubMed | ||
| 82403045 | National Natural Science Foundation of China | PubMed | PubMed | ||
| BK20240372 | Natural Science Foundation of Jiangsu Province | PubMed | PubMed | ||
| KJXW2023005 | Youth Science and Technology of Suzhou Science and Education Project | PubMed | PubMed | ||
| RKYCX202603 | Hospital of Soochow University of Prof. Changgeng Ruan's Research and Innovation Fund for Graduate Students | RKYCX202603 | PubMed | NIH RePORTER | |
| Clinical Medicine peak project of Suzhou Medical College of Soochow University | PubMed | PubMed | |||
| Leading talent project of "Boxi Excellent Talent Training Plan" of the First Affiliated Hospital of Soochow University | PubMed | PubMed |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38,956,074 | Semaphorin 3C (Sema3C) reshapes stromal microenvironment to promote hepatocellular carcinoma progression. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/38956074 | PubMed |
| 2 | 41,238,541 | A preserved TGFβ cytostatic response through DLD-mediated metabolic modulation undermines anti-TGFβ therapy in gastric cancer. | Nat Commun | 2025 | https://conductscience.org/library/papers/41238541 | PubMed |
| 3 | 41,331,087 | Lineage-determining transcription factors constrain cohesin to drive multi-enhancer oncogene regulation. | Nat Cell Biol | 2026 | https://conductscience.org/library/papers/41331087 | PubMed |
| 4 | 37,914,930 | Glioma synapses recruit mechanisms of adaptive plasticity. | Nature | 2023 | https://conductscience.org/library/papers/37914930 | PubMed |
| 5 | 35,318,442 | HNF4A-AS1-encoded small peptide promotes self-renewal and aggressiveness of neuroblastoma stem cells via eEF1A1-repressed SMAD4 transactivation. | Oncogene | 2022 | https://conductscience.org/library/papers/35318442 | PubMed |
| 6 | 39,413,197 | Semaphorin 3D promotes pancreatic ductal adenocarcinoma progression and metastasis through macrophage reprogramming. | Sci Adv | 2024 | https://conductscience.org/library/papers/39413197 | PubMed |
| 7 | 36,859,428 | Inhibition of ALKBH5 attenuates I/R-induced renal injury in male mice by promoting Ccl28 m6A modification and increasing Treg recruitment. | Nat Commun | 2023 | https://conductscience.org/library/papers/36859428 | PubMed |
| 8 | 40,640,851 | Knocking down hypoxia-induced Semaphorin 6B may attenuate the progression of cervical cancer through regulating macrophage M2 polarization. | J Transl Med | 2025 | https://conductscience.org/library/papers/40640851 | PubMed |
| 9 | 30,216,699 | Jack of many trades: Multifaceted role of neuropilins in pancreatic cancer. | Cancer Med | 2018 | https://conductscience.org/library/papers/30216699 | PubMed |
| 10 | 37,980,571 | Genome-wide profiling of transcription factor activity in primary liver cancer using single-cell ATAC sequencing. | Cell Rep | 2023 | https://conductscience.org/library/papers/37980571 | PubMed |
1 to 10 of 43
See all 43 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first.
None in this release.
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42880979
GET https://conductscience.org/api/papers/v1/42880979/references?page=2